No Easy Road for POC Molecular Diagnostics in Developing World: White Paper

   Single User - $0

Published Apr 24, 2017 | 2 Pages | Pub ID: KLI15326411

This White Paper looks at the probability of success for molecular POC in developing nations.   The sensitivity and specificity of nucleic acid analytes provide molecular diagnostics key advantages in clinical practice, particularly in critical health situations. Nucleic acid amplification (NAATs) or molecular tests are now open to routine and distributed use in healthcare thanks to advancements in microfluidics and molecular reagents.  As molecular diagnostics enter point-of-care (POC) settings, cost becomes a key issue in comparison to predominantly used and cheaply performed rapid immunoassays.

For a complete analysis of the Molecular POC market, including market numbers for various categories, the White Paper contains a link to our full report on the topic.  
  • About Molecular POC
  • Emerging World Situation
  • Kalorama Informaiton's The Market and Future Potential for Molecular POC Diagnostics

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.